Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer

…, DV Sahani, SP Kalva, SV Kozin, M Mino, KS Cohen… - Nature medicine, 2004 - nature.com
The effects of vascular endothelial growth factor (VEGF) blockade on the vascular biology of
human tumors are not known. Here we show here that a single infusion of the VEGF-specific …

[HTML][HTML] Randomized trial of metformin, ivermectin, and fluvoxamine for Covid-19

…, DM Liebovitz, JM Nicklas, K Cohen… - … England Journal of …, 2022 - Mass Medical Soc
Background Early treatment to prevent severe coronavirus disease 2019 (Covid-19) is an
important component of the comprehensive response to the severe acute respiratory …

[HTML][HTML] Phase II study of cediranib, an oral pan–vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma

…, T Benner, DN Louis, KS Cohen… - Journal of Clinical …, 2010 - ncbi.nlm.nih.gov
Purpose Glioblastoma is an incurable solid tumor characterized by increased expression of
vascular endothelial growth factor (VEGF). We performed a phase II study of cediranib in …

[PDF][PDF] AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients

…, E di Tomaso, WT Zhang, DG Duda, KS Cohen… - Cancer cell, 2007 - cell.com
Using MRI techniques, we show here that normalization of tumor vessels in recurrent
glioblastoma patients by daily administration of AZD2171—an oral tyrosine kinase inhibitor of …

3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial

…, RS Call, R Canadas, LB Chaykin, K Cohen… - The Lancet, 2017 - thelancet.com
Background Liraglutide 3·0 mg was shown to reduce bodyweight and improve glucose
metabolism after the 56-week period of this trial, one of four trials in the SCALE programme. In …

Quantum dots spectrally distinguish multiple species within the tumor milieu in vivo

…, JP Zimmer, DG Duda, TS Levchenko, KS Cohen… - Nature medicine, 2005 - nature.com
A solid tumor is an organ composed of cancer and host cells embedded in an extracellular
matrix and nourished by blood vessels. A prerequisite to understanding tumor …

[BOOK][B] The way of qigong: The art and science of Chinese energy healing

KS Cohen - 1999 - books.google.com
… "Ken Cohen is a rare combination of expert practitioner, gifted scholar, and lucid writer. He
… For those interested in optimal health, Ken Cohen's book allows you an opportunity not only …

[HTML][HTML] Intensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumor

SN Chi, MA Zimmerman, X Yao, KJ Cohen… - Journal of clinical …, 2009 - ncbi.nlm.nih.gov
Purpose Atypical teratoid rhabdoid tumor (ATRT) of the CNS is a highly malignant neoplasm
primarily affecting young children, with a historic median survival ranging from 6 to 11 …

Temozolomide in the treatment of high-grade gliomas in children: a report from the Children's Oncology Group

KJ Cohen, IF Pollack, T Zhou, A Buxton… - Neuro …, 2011 - academic.oup.com
To determine whether temozolomide is an active agent in the treatment of children with high-grade
astrocytomas and whether survival is influenced by the expression of the O6-…

Differential in vivo potential of endothelial progenitor cells from human umbilical cord blood and adult peripheral blood to form functional long-lasting vessels

P Au, LM Daheron, DG Duda, KS Cohen… - Blood, The Journal …, 2008 - ashpublications.org
Tissue engineering requires formation of a de novo stable vascular network. Because of
their ability to proliferate, differentiate into endothelial cells, and form new vessels, blood-…